The global biosimilar market reached a value of USD 24.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.60% from 2024 to 2032. This significant growth trajectory is driven by the increasing demand for affordable biopharmaceutical alternatives, the rising prevalence of chronic diseases, and the rapid advancements in biotechnology. By 2032, the market is...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek